Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-05-18 @ 12:32 AM
Study NCT ID:
NCT05776134
Status:
AVAILABLE
Last Update Posted:
2025-01-10
First Post:
2023-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Sponsor:
Kite, A Gilead Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KT-US-472-0141
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None